
To diagnose either type 2 diabetes or pre-diabetes, clinicians typically rely on a lab value known as HbA1c. This test captures a person’s average blood glucose levels over the previous few months. But HbA1c cannot predict who is at highest risk of progressing from healthy to prediabetic, or from prediabetic to full-blown diabetes.
Now, scientists at Scripps Research have discovered that artificial intelligence can use a combination of other data—including real-time glucose levels from wearable monitors—to provide a more nuanced view of diabetes risk.
The new model, described in Nature Medicine, uses continuous glucose monitor (CGM) data alongside gut microbiome, diet, ph...
Read More






Recent Comments